Airwatch LLC

Polaroid Corporation

Tapestry Pharmaceuticals, Inc.

Other

Zink Imaging, Inc.

E Ink Corporation

Vmware, Inc.

Tally LLC

Omnissa, LLC

Polaroid Corporatiion

John L Marshall

Stephen J Telfer

Erich Peter Stuntebeck

James D McChesney

Gilles Hugues Tapolsky

Michael Kurman

Manuel R Modiano

David Lloyd Emerson

Richard A Minns

Jurgen M Grasshoff

Michael P Filosa

Anthony J Puttick

Stephen G Stroud

Lloyd D Taylor

Alan James Dabbiere

Socorro M Ramos

John Joseph Manton

Larry C Takiff

Gopinath Jayaprakash

Eric S Kolb

Roger A Boggs

John M Hardin

Kap-Soo Cheon

Jonathon Blake Brannon

Haixin Yang

Russell A Gaudiana

Adam Stephen Rykowski

Mark R Mischke

Fariza B Hasan

Eugene Bzowej

Richard M Allen

Serajul Haque

Tauseef Ahmed

Allen Cohn

Jyothiprakash Halebeed

Brandon Ian MacDonald

Donald A McGowan

Michael J Zuraw

John C Warner

William DeWeese

Michael A Young

John W Lee

Christian Blake Sorensen

Ronald W Greene

Paulina P Garcia

Thomas K Spencer

Robert W Haddock

David E Emerson

Rita S Baker

Jonathan Blake Brannon

Richard J Paolini, Jr

Kenneth R Crounse

David P Waller

William T Vetterling

Jay William Anseth

Alain Bouchard

Lee Yezek

Michael J Arnost

Michael S Viola

Yongqi Deng

Erich Stuntebeck

Ziyan Wu

Joanna F Au

Edward D Bringhurst

James A Foley

Edward J Dombrowski

Anne Ehret

Iris B Kliman Bloom

Lee E Hughes

Dieter Doring

Henry B Clark, Jr

Xavier Herault

Brandon Macdonald

David A Skyler

Blake Sorensen

Mixtures are disclosed containing a plurality of charged pigment particles and one or more charge control agents. At least one of the charge control agents has a chemical structure that includes a cationic head group, such as an ammonium cation or an iminium compound, and a non-ionic, polar functional group, other than an acyclic secondary amide group. The mixtures are useful as dispersions for forming electrophoretic media that may be incorporated into electrophoretic displays. Alternatively, the dispersions may be useful for forming electrophotographic toners and dispersions for other printing applications.

Charge control agents and particle dispersions including the same

Disclosed are various embodiments for controlling access to data on a network. Upon receiving a request comprising a device identifier and at least one user credential to access a remote resource, the request may be authenticated according to at least one compliance policy. If the request is authenticated, a resource credential associated with the remote resource may be provided.

Controlling access to resources on a network

Mixtures are disclosed containing a plurality of charged pigment particles and a one or more charge control agents. At least one of the charge control agents has a chemical structure that includes a cationic head group, such as an ammonium cation or an iminium compound, and a non-ionic, polar functional group, other than an acyclic secondary amide group. The mixtures are useful as dispersions for forming electrophoretic media that may be incorporated into electrophoretic displays. Alternatively, the dispersions may be useful for forming electrophotographic toners and dispersions for other printing applications.

Disclosed are various embodiments for accessing resources when a client device complies with distribution rules. A client device receives distribution rules associated with resources that are accessible at a distribution service. The client device determines whether the client device complies with the distribution rules. The client device transmits an indication of compliance for the distribution to the distribution service. The client device receives the resource from the distribution service.

Controlling distribution of resources in a network

Resource watermarking and management actions on electronic resources are described. In one example, a process for resource watermarking and management actions includes receiving, from a client device, a request to perform an action on an electronic resource and a device profile for the client device. The device profile can include at least one attribute of the client device. The process also includes identifying a watermark template for the electronic resource, determining descriptive data of the watermark template based on the request to perform the action and whether the device profile complies with a compliance rule, overlaying the watermark template and the descriptive data onto the electronic resource, and determining that the client device is authorized to perform the action on the electronic resource in response to the electronic resource being united with the watermark template.

Resource watermarking and management

Disclosed are various embodiments for controlling a distribution of resources on a network. In one example, among others, a system is configured to receive the plurality of resources and a plurality of rules. The system is also configured to determine an authorized location and an authorized area based on the plurality of rules. The authorized location and the authorized area are determined to have different access rights to the plurality of resources. The system is further configured to determine a location of the computing device and grant access to a resource based on the location of the computing device with respect to the authorization location or the authorized area.

Controlling distribution of resources on a network

Time-based functionality restrictions may be provided. Periodic scans may be performed to identify requests to perform functions on user devices, to determine whether the functions are compliant with compliance rules associated with the user devices that specify time periods during which the user devices are authorized to perform the functions, and to perform remedial actions if the functions are not compliant with the compliance rules.

Time-based functionality restrictions

The present invention relates to a novel chemical compound for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Biologically active taxane analogs and methods of treatment by oral administration

Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.

Taxane analogs for the treatment of brain cancer

A temperature regulation system includes a laminate material that has a first light transmissive electrode layer, a rear electrode layer, and a bistable electrophoretic medium disposed between the first and second electrode layer. The electrophoretic medium includes two types of particles that have different charges and color. The amount of incident radiation (visible light, infrared, etc.) that is absorbed by the laminate can be modified by providing a voltage between the electrode layers.

Solar temperature regulation system for a fluid

Disclosed are various embodiments for controlling a distribution of resources on a network. In one example, among others, a system is configured to transmit a request to access a plurality of resources at a distribution service and receive the plurality of resources and a plurality of location rules. The system is also configured to determine an authorized location and an authorized perimeter area based on the plurality of location rules. The authorized location and the authorized perimeter area are determined to have different access rights to the plurality of resources. The system is further configured to determine a location of the computing device and grant access to a resource based on the location of the computing device with respect to the authorization location or the authorized perimeter.

An electrophoretic medium includes a fluid, a plurality of light scattering charged particles having a first polarity, and a first, second, and third set of particles, each set having a color different from each other set. The first and second particles may have a second polarity opposite to the first polarity, and the mobility of the third set of particles is less than half of the mobility of the light scattering particles, the first set of charged particles, and the second set of charged particles.

Colored electrophoretic displays

The present invention relates to a novel chemical compound for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents. 

Location-based configuration profile toggling may be provided. Configuration profiles associated with user devices may be identified, determinations of whether the user devices are authorized to enable the configuration profiles on the user devices may be made based at least in part on location constraints, and the configuration profiles may be enabled an the user devices if the location constraints are satisfied.

Location-based configuration profile toggling

Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubules at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.

Growing community of inventors

Somerville, MA, United States of America

John L Marshall